Samsara BioCapital, LLC - ALLOVIR INC ownership

Quarter-by-quarter ownership
Samsara BioCapital, LLC ownership history of ALLOVIR INC
ValueSharesWeighting
Q3 2023$177,022
-36.8%
82,3360.0%0.05%
+10.2%
Q2 2023$279,942
-13.7%
82,3360.0%0.05%
-26.9%
Q1 2023$324,404
-23.2%
82,3360.0%0.07%
-26.4%
Q4 2022$422,384
-35.0%
82,3360.0%0.09%
-40.1%
Q3 2022$650,000
+102.5%
82,3360.0%0.15%
+76.7%
Q2 2022$321,000
-42.3%
82,3360.0%0.09%
-38.6%
Q1 2022$556,000
-47.8%
82,3360.0%0.14%
-32.4%
Q4 2021$1,065,000
-48.4%
82,3360.0%0.21%
-36.1%
Q3 2021$2,063,000
+27.0%
82,3360.0%0.32%
+61.2%
Q2 2021$1,625,000
-15.7%
82,3360.0%0.20%
-43.4%
Q1 2021$1,927,000
-39.1%
82,3360.0%0.36%
+11.6%
Q4 2020$3,165,000
+26.4%
82,336
-9.6%
0.32%
-54.4%
Q3 2020$2,504,00091,0570.70%
Other shareholders
ALLOVIR INC shareholders Q4 2023
NameSharesValueWeighting ↓
Artal Group S.A. 2,323,371$89,310,0001.92%
Redmile Group, LLC 2,325,595$89,396,0001.08%
Woodline Partners LP 1,039,880$39,973,0001.06%
EcoR1 Capital, LLC 447,012$17,183,0000.92%
Samsara BioCapital, LLC 82,336$3,165,0000.32%
CNA FINANCIAL CORP 11,285$434,0000.14%
AMERICAN INTERNATIONAL GROUP, INC. 910,419$34,997,0000.13%
Virtus ETF Advisers LLC 7,339$282,0000.12%
Maven Securities LTD 19,901$799,0000.08%
TCW GROUP INC 216,135$8,308,0000.07%
View complete list of ALLOVIR INC shareholders